The Battle against Biofilms: A Focus on Novel Antimicrobial Strategies and Their Mechanisms of Action

Dear Colleagues,

Biofilms are the default microbial growth mode in most environments, including both natural and human-made ones. These protect the enclosed cells from environmental perturbations, including physicochemical stresses and biocide exposure. In addition to their beneficial roles, mainly with respect to their crucial involvement in environmental sustainability issues (e.g., bioremediation, wastewater treatment, bioreactors producing beneficial compounds), biofilms are mostly known for the important problems these provoke in many areas, including persistent human infections, biofouling of medical devices (e.g., catheters, prosthetic heart valves), food contamination, surface corrosion, crop losses, problems in marine traffic, productivity losses, and considerable increases in energy consumption. The increased recalcitrance of biofilms to current antimicrobials has led to the search for novel, cost-efficient, and preferable eco-friendly antimicrobial strategies to combat them. These should be able to destroy the biofilm cells with the lowest possibilities for subsequent resistance development. This Special Issue seeks manuscripts dealing with novel antibiofilm strategies, especially those trying to unravel their modes of action at the sessile community and cellular levels. Both original research and review articles are welcome.

Dr. Efstathios Giaouris
Dr. Olivier Habimana
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.